Holen Sie sich die Stockscreener-App
1.09
5.83%
0.06
Handel nachbörslich:
1.09
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
Standard BioTools shares hold over $1 as Nasdaq deadline nears - Bez Kabli
Standard BioTools (LAB) Hovers Near Support After Modest DeclineOpening Range Breakout - Newser
Standard BioTools (LAB) Nears Support After Slight Decline Amid Cautious TradingNews Sentiment - Newser
STANDARD BIOTOOLS (LAB) CFO has 18,871 shares withheld for RSU taxes - Stock Titan
Standard Biotools (LAB) SVP has 25,729 shares withheld for taxes - Stock Titan
STANDARD BIOTOOLS (LAB) CEO has shares withheld to cover RSU tax obligations - Stock Titan
Standard BioTools Q1 2026 Earnings: Massive EPS Beat Fails to Lift Shares Amid Revenue UncertaintyProfit Announcement - Newser
DKSH : and Standard BioTools Announce Distribution Partnership to Expand Spatial Biology and Proteomics Solutions in Australia and New Zealand - marketscreener.com
Standard BioTools (LAB) Q1 2026 Earnings: $0.33 EPS Surges Past $-0.06 EstimatesStock Idea Hub - Newser
Standard BioTools (LAB) Q1 2026 Earnings Surprise: EPS $0.33, Up SignificantCrowd Consensus Signals - Newser
SomaLogic stock (US82489T1043): merger with Standard BioTools reshapes proteomics player - AD HOC NEWS
SomaLogic Inc stock (US82489T1043): Illumina merger closes and reshapes proteomics story - AD HOC NEWS
MAK Capital (NASDAQ: LAB) reports 6.7% stake in Standard BioTools - Stock Titan
Viking Global (LAB) holds 58.65M shares (~15%) of Standard BioTools - Stock Titan
Should You Sell Standard BioTools (LAB) After -1.52% Drop? 2026-05-15Collaborative Trading Signals - Newser
Standard BioTools (LAB) Q1 2026 Earnings: Why the Beat MattersBinary Event - newser.com
SomaLogic stock (US82489T1043): Completed $350M sale to Illumina - AD HOC NEWS
MSN Money - MSN
Standard BioTools (LAB) reports Q1 loss, tops revenue estimates - MSN
Standard BioTools Inc. (LAB) Stock Analysis: A 55% Potential Upside Beckons Investors - DirectorsTalk Interviews
Standard Biotools Faces Nasdaq Delisting Risk After Prolonged Sub-$1 Share Price - TipRanks
Number of shareholders of Standard BioTools Inc. – NASDAQ:LAB - TradingView
Standard BioTools (NASDAQ: LAB) posts Q1 2026 profit on SomaScan sale windfall - Stock Titan
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry - MSN
LAB Financials: Income Statement, Balance Sheet & Cash Flow | STANDARD BIOTOOLS INC - Stock Titan
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Standard BioTools: Q1 Earnings Snapshot - marketscreener.com
Standard BioTools Highlights Improved Q1 2026 Results, Outlook - TipRanks
Standard BioTools 1Q Loss $14.6M >LAB - Moomoo
Standard BioTools 1Q Rev $21.1M >LAB - Moomoo
Standard BioTools ends quarter with $524M as loss shrinks 54% - Stock Titan
Standard BioTools (LAB) Q1 2026 results show big cash boost and EBITDA gains - Stock Titan
Standard BioTools Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Standard BioTools Reports First Quarter 2026 Financial Results - ChartMill
LAB (Standard BioTools) posts strong Q4 2025 EPS beat, with shares registering mild gains in recent trading.EBITDA Analysis - Newser
Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026 - Investing News Network
1.27%
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):